Product Images Ganciclovir
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Ganciclovir NDC 51817-171 by Pharmascience Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Box label 1
Ganciclovir Injection is a sterile, nonpyrogenic, preservative-free cytotoxic agent used for intravenous infusion only. It is available in a single-dose vial containing 500mg/10mL of Ganciclovir and should be handled with great care due to its potent cytotoxic properties and suspected carcinogenic effect. The product is manufactured by Pharmascience Inc. in Candiac, Canada. For dosage recommendations and important prescribing information, refer to the accompanying insert.*
Box label 25
Chemical structure of ganciclovir sodium and ganciclovir - Ganciclovir image 1 chemical structure
Figure 1 Trial ICM 1653: Time to Progression of CMV Retinitis - Ganciclovir image 2 ICM 1653
This is a graph titled "ICM 1653: Time to Progression of CMV Retinitis". It shows the time from the start of maintenance therapy (in days) on the x-axis and the proportion without progression on the y-axis. The values range from 0-150 days and the highest proportion without progression is at day 60 with a value of 0.75.*
Figure 2 Trial ICM 1774: Time to Progression of CMV Retinitis - Ganciclovir image 3 ICM 1774
The text describes a graph or chart titled "ICM 1774: Time to Progression of CMV Retinitis". It shows the proportion of individuals with CMV retinitis who did not experience progression over time (measured in days) while receiving oral maintenance therapy. The graph starts at day zero and goes up to day 120.*
Figure 3 Trial AVI 034: Time to Progression of Retinitis - Ganciclovir image 4 AVI 034
This is a graph labeled "AVI 034: Time to Progression of CMV Retinitis" which shows the proportion of patients without progression of CMV retinitis over time from the start of maintenance therapy, measured in days. The x-axis ranges from 0 to 150 days and the y-axis ranges from 0.25 to 0.75. There is no additional information available.*
Vial label
Ganciclovir Injection is a sterile solution for intravenous infusion only. Each 10mL single-dose vial contains 500mg of ganciclovir. The container closure is not made with natural rubber latex and is sterile, nonpyrogenic and preservative-free. However, caution is advised as it is a cytotoxic agent and suspected carcinogen. Dosage information can be found in the package insert. The product should be handled with great care and any unused portion should be discarded. It is manufactured by Pharmascience Inc in Canada. Store at 25°C (17°F); excursions permitted to 15°-30°C (59°-46°F).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.